IL-28B genetic polymorphism as a Predictor for Efficacy of Treatment with Interferon in Egyptian Hepatitis C Patients

  • Khalda Sayed Amr, Hanan AbdElmawgood Atia, Lilian Nabil Naoum, Samah Shehata Mohammed
  • Published 2014

Abstract

Hepatitis C is a global health problem and represents a major cause of liver disease and socioeconomic burden. Effective antiviral therapy may prevent these complications, but the current treatment for patients with chronic hepatitis C virus (HCV) infection does not achieve sustained virological response (SVR) for all patients. Therefore, identification of… (More)

Topics

Cite this paper

@inproceedings{Amr2014IL28BGP, title={IL-28B genetic polymorphism as a Predictor for Efficacy of Treatment with Interferon in Egyptian Hepatitis C Patients}, author={Khalda Sayed Amr and Hanan AbdElmawgood Atia and Lilian Nabil Naoum and Samah Shehata Mohammed}, year={2014} }